Schonfeld Strategic Advisors LLC

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1665241 NEW YORK, NY

Position in MRVI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$414,566

-$794,761 QoQ

Shares Held

66,437

-87.9% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#91

of 177 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. MRVI ranks #90 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$414,566	66,437	-87.9%	Shares	Sole	2026-08-14
2025-03-31	$1,209,327	547,207	+2.5%	Shares	Sole	2025-05-15
2024-12-31	$2,908,354	533,643	+1960.4%	Shares	Sole	2025-02-14
2024-09-30	$215,229	25,900	+64.0%	Shares	Sole	2024-11-14
2024-03-31	$136,951	15,796	-71.8%	Shares	Sole	2024-05-15
2023-12-31	$367,455	56,100	+375.4%	Shares	Sole	2024-02-14
2023-06-30	$146,674	11,800	-66.8%	Shares	Sole	2023-08-14
2022-12-31	$508,405	35,528	-42.5%	Shares	Sole	2023-02-14
2022-03-31	$2,179,686	61,800	-10.3%	Shares	Sole	2022-05-16
2021-12-31	$2,887,496	68,914	+429.7%	Shares	Sole	2022-02-14
2021-09-30	$638,530	13,010	-38.7%	Shares	Sole	2021-11-16
2021-06-30	$885,969	21,231	-49.1%	Shares	Sole	2021-11-16
2021-03-31	$1,486,188	41,700	+101.5%	Shares	Sole	2021-05-17
2020-12-31	$580,494	20,695	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.